Abiopharma

🔍 SIEBEL THOMAS M (Director)

Company: C3.ai, Inc. (AI)

Report Date: 2026-04-13

Detailed Transactions and Holdings:

• Acquired 326,189 shares of Class A Common Stock at $2.04 per share (Direct)
  Date: 2026-04-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,048,551.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 326,189 shares of Class A Common Stock at $8.31 per share (Direct)
  Date: 2026-04-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 722,362.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 165,278 shares of Class A Common Stock at $2.04 per share (Direct)
  Date: 2026-04-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 887,640.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 165,278 shares of Class A Common Stock at $8.49 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 722,362.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 694,188.00 | Footnotes: F4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 9,216.00 | Footnotes: F5
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 170,294.00 | Footnotes: F6
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 72,695.00 | Footnotes: F7
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 1,237,115.00 | Footnotes: F8
• Sold 326,189 shares of Stock Option (Right to Buy) at $2.04 per share (Derivative)
  Date: 2026-04-13 | Code: M | Expires: 2027-11-07 | equity_swap_involved: 0 | shares_owned_after: 1,447,996.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 165,278 shares of Stock Option (Right to Buy) at $2.04 per share (Derivative)
  Date: 2026-04-14 | Code: M | Expires: 2027-11-07 | equity_swap_involved: 0 | shares_owned_after: 1,282,718.00 | transaction_form_type: 4 | Footnotes: F1, F9

Footnotes:

• F1: The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan dated September 20, 2024.
• F2: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.92 to $8.52, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F3: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $8.74, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F4: The shares are held by The Siebel Living Trust u/a/d 7/27/93, as amended, of which the Reporting Person is trustee.
• F5: The shares are held by First Virtual Holdings, LLC, of which the Reporting Person is Chairman.
• F6: The shares are held by Siebel Asset Management, L.P., of which the Reporting Person is the general partner.
• F7: The shares are held by Siebel Asset Management III, L.P., of which the Reporting Person is the general partner.
• F8: The shares are held by The Siebel 2011 Irrevocable Children's Trust, of which the Reporting Person is co-trustee.
• F9: Fully vested.